胰岛素可以作为神经精神病症状的新疗法吗?
Fatemeh Rahmati-Dehkordi1,2,3, Nafiseh Birang4, Mohammad Naser Jalalian5
1Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Naunyn-Schmiedeberg's archives of pharmacology
|September 3, 2024
概括
炎症性疾病的治疗方法Infliximab通过向瘤缩因子alpha来治疗神经精神疾病,这表明它对神经精神疾病有前途. 需要进一步的研究来确认其潜在的治疗益处.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 精神病学是一个精神病学.
背景情况:
- 神经精神疾病是一个重大的全球健康挑战.
- 关键的病因因素包括亡,氧化应激和神经炎症.
- 瘤亡因子α (TNF-α) 在这些疾病的病理生理学中起着至关重要的作用.
研究的目的:
- 审查当前关于TNF-α在神经精神疾病中的作用的知识.
- 探索TNF-α抑制剂Infliximab作为治疗这些疾病的治疗剂的潜力.
- 强调需要进一步描述神经精神病治疗中的因弗利西马布.
主要方法:
- 对当代科学知识的文献综述.
- 对Infliximab在炎症和神经精神疾病中的疗效现有数据的分析.
- 关于神经精神疾病中TNF-α通路的证据综合.
主要成果:
- 恩弗利西马布是治疗性结肠炎,克罗恩病和类风湿性关节炎等炎症性疾病的既定治疗方法.
- 新出现的证据表明,infliximab可以改善认知功能障碍,抑郁和焦虑.
- 因弗利西马布对TNF-α的抑制为神经精神疾病提供了潜在的治疗途径.
结论:
- 因弗利西马布的抗炎性质,特别是其抑制TNF-α,与神经精神疾病有关.
- 目前的研究结果支持研究因弗利西马布作为一种新的治疗策略.
- 进一步的临床表征是必要的,以确定infliximab在神经精神病患者群体的疗效和安全性.
更多相关视频
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:29Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
01:26Psychosis: Goals of Pharmacotherapy
113
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
113
01:28Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40